310 related articles for article (PubMed ID: 25797366)
1. Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France.
Ribadeau Dumas F; N'Diaye DS; Paireau J; Gautret P; Bourhy H; Le Pen C; Yazdanpanah Y
Vaccine; 2015 May; 33(20):2367-78. PubMed ID: 25797366
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of rabies post exposure prophylaxis in Iran.
Hatam N; Esmaelzade F; Mirahmadizadeh A; Keshavarz K; Rajabi A; Afsar Kazerooni P; Ataollahi M
J Res Health Sci; 2014; 14(2):122-7. PubMed ID: 24728746
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of operating Animal Bite Treatment Centers in the Philippines from a health provider perspective.
Amparo ACB; Jayme SI; Roces MCR; Quizon MCL; Villalon EES; Quiambao BP; Baquilod MS; Hernandez LM; Taylor LH; Nel LH
PLoS One; 2018; 13(7):e0199186. PubMed ID: 30001378
[TBL] [Abstract][Full Text] [Related]
4. Rabies vaccination strategies in the Netherlands in 2018: a cost evaluation.
Suijkerbuijk AW; Mangen MJ; Haverkate MR; Luppino FS; Bantjes SE; Visser LG; Swaan CM; Ruijs WL; Over EA
Euro Surveill; 2020 Sep; 25(38):. PubMed ID: 32975187
[TBL] [Abstract][Full Text] [Related]
5. Post-exposure rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2012-2015 - A retrospective study.
Krzowska-Firych J; Tomasiewicz K; Kozøowska A
Hum Vaccin Immunother; 2017 Jun; 13(6):1-6. PubMed ID: 28166482
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness modelling studies of all preventive measures against rabies: A systematic review.
Anothaisintawee T; Julienne Genuino A; Thavorncharoensap M; Youngkong S; Rattanavipapong W; Meeyai A; Chaikledkaew U
Vaccine; 2019 Oct; 37 Suppl 1():A146-A153. PubMed ID: 30554795
[TBL] [Abstract][Full Text] [Related]
7. Health economic assessment of a rabies pre-exposure prophylaxis program compared with post-exposure prophylaxis alone in high-risk age groups in the Philippines.
Quiambao B; Varghese L; Demarteau N; Sengson RF; Javier J; Mukherjee P; Manio LC; Preiss S
Int J Infect Dis; 2020 Aug; 97():38-46. PubMed ID: 32450291
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness Evaluation of a Novel Integrated Bite Case Management Program for the Control of Human Rabies, Haiti 2014-2015.
Undurraga EA; Meltzer MI; Tran CH; Atkins CY; Etheart MD; Millien MF; Adrien P; Wallace RM
Am J Trop Med Hyg; 2017 Jun; 96(6):1307-1317. PubMed ID: 28719253
[TBL] [Abstract][Full Text] [Related]
9. Human rabies post exposure prophylaxis in Bhutan, 2005-2008: trends and risk factors.
Tenzin ; Dhand NK; Ward MP
Vaccine; 2011 May; 29(24):4094-101. PubMed ID: 21497633
[TBL] [Abstract][Full Text] [Related]
10. Wound-only injection of rabies immunoglobulin (RIG) saves lives and costs less than a dollar per patient by "pooling strategy".
Bharti OK; Thakur B; Rao R
Vaccine; 2019 Oct; 37 Suppl 1():A128-A131. PubMed ID: 31395454
[TBL] [Abstract][Full Text] [Related]
11. The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study.
WHO Rabies Modelling Consortium
Lancet Infect Dis; 2019 Jan; 19(1):102-111. PubMed ID: 30472178
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of urban dog-related injuries requiring rabies post-exposure prophylaxis in Marseille, France.
Gautret P; Le Roux S; Faucher B; Gaudart J; Brouqui P; Parola P
Int J Infect Dis; 2013 Mar; 17(3):e164-7. PubMed ID: 23116608
[TBL] [Abstract][Full Text] [Related]
13. Rabies Vaccine and Rabies Immunoglobulin in Cambodia: Use and Obstacles to Use.
Tarantola A; Ly S; In S; Ong S; Peng Y; Heng N; Buchy P
J Travel Med; 2015; 22(5):348-52. PubMed ID: 26173470
[TBL] [Abstract][Full Text] [Related]
14. Awareness about rabies post exposure prophylaxis in Pakistan among patients and health care workers: results from an Asian Rabies Expert Bureau study.
Salahuddin N; Jamali S; Ibraheem K; Sardar S
J Coll Physicians Surg Pak; 2011 Aug; 21(8):491-4. PubMed ID: 21798137
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania.
Shim E; Hampson K; Cleaveland S; Galvani AP
Vaccine; 2009 Nov; 27(51):7167-72. PubMed ID: 19925948
[TBL] [Abstract][Full Text] [Related]
16. Human rabies post exposure prophylaxis at the Pasteur Institute of Dakar, Senegal: trends and risk factors.
Diallo MK; Diallo AO; Dicko A; Richard V; Espié E
BMC Infect Dis; 2019 Apr; 19(1):321. PubMed ID: 30975098
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of post-exposure prophylaxis practices to improve the cost-effectiveness of rabies control in human cases potentially exposed to rabies in southern Bhutan.
Penjor K; Marquetoux N; Dorji C; Penjor K; Dorjee S; Dorjee C; Jolly PD; Morris RS; McKenzie JS
BMC Infect Dis; 2020 Mar; 20(1):203. PubMed ID: 32143641
[TBL] [Abstract][Full Text] [Related]
18. Cost of rabies post exposure prophylaxis in different healthcare settings in six states of India.
Haradanhalli RS; D Hanumanthaiah AN; Varadappa ST
Indian J Public Health; 2019 Sep; 63(Supplement):S44-S47. PubMed ID: 31603091
[TBL] [Abstract][Full Text] [Related]
19. Update on human rabies in a dog- and fox-rabies-free country.
Stahl JP; Gautret P; Ribadeau-Dumas F; Strady C; Le Moal G; Souala F; Maslin J; Fremont B; Bourhy H
Med Mal Infect; 2014 Jul; 44(7):292-301. PubMed ID: 25011930
[TBL] [Abstract][Full Text] [Related]
20. Should travellers to rabies-endemic countries be pre-exposure vaccinated? An assessment of post-exposure prophylaxis and pre-exposure prophylaxis given to Danes travelling to rabies-endemic countries 2000-12.
Christiansen AH; Rodriguez AB; Nielsen J; Cowan SA
J Travel Med; 2016 Apr; 23(4):. PubMed ID: 27147729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
